Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 May 4.
Published in final edited form as: Angew Chem Int Ed Engl. 2020 Mar 10;59(19):7367–7371. doi: 10.1002/anie.201914896

Pathway from N-alkylglycine to alkylisonitrile catalyzed by iron(II) and 2-oxoglutarate dependent oxygenases

Tzu-Yu Chen [a],, Jinfeng Chen [b],, Yijie Tang [c], Jiahai Zhou [b], Yisong Guo [c], Wei-chen Chang [a]
PMCID: PMC7180123  NIHMSID: NIHMS1573496  PMID: 32074393

Abstract

N-alkylisonitrile, a precursor to isonitrile-containing lipopeptides, is biosynthesized via decarboxylation-assisted -N≡C group (isonitrile) formation by using N-alkylglycine as the substrate. This reaction is catalyzed by iron(II) and 2-oxoglutarate (Fe/2OG) dependent enzymes. Distinct from typical oxygenation or halogenation reactions catalyzed by this class of enzymes, installation of the isonitrile group represents a novel reaction type for Fe/2OG enzymes that involves a four-electron oxidative process. Reported here is a plausible mechanism of three Fe/2OG enzymes, Sav607, ScoE and SfaA, which catalyze isonitrile formation. The X-ray structures of iron-loaded ScoE in complex with its substrate and the intermediate, along with biochemical and biophysical data reveal that -N≡C bond formation involves two cycles of Fe/2OG enzyme catalysis. The reaction starts with an Fe(IV)-oxo catalyzed hydroxylation. It is likely followed by decarboxylation-assisted desaturation to complete isonitrile installation.

Keywords: Fe/2OG enzyme, isonitrile, enzyme mechanism, decarboxylation, catalysis

Graphical Abstract

graphic file with name nihms-1573496-f0001.jpg

A subclass of Fe/2OG (2-oxoglutarate) enzyme catalyzes decarboxylation-assisted desaturation of N-alkyl glycine to install the isonitrile functionality. By using a complementary approach including structure determination, NMR, and Mössbauer analyses, the reaction intermediate and plausible reaction mechanism is established.


Isonitrile-containing natural products have shown diverse biological activities.[1] Notably, two types of enzymes are involved in isonitrile formation (Scheme 1A). The first type employs an isonitrilase catalyzed condensation of the amine from the L-tyrosine/tryptophan with the carbonyl group of ribulose-5-phoshate.[2] The second type involves an iron(II) and 2-oxoglutarate (Fe/2OG) dependent enzyme catalyzed decarboxylation-assisted -N≡C group installation.[3] Analysis of the biosynthetic gene clusters responsible for the Fe/2OG enzyme catalyzed isonitrile formation revealed that the pathway involved in isonitrile-containing peptides production is conserved in pathogenic mycobacteria including Mycobacterium tuberculosis, and M. marinum. Related operons are also found in the phylum of Actinobacteria including Streptomyces.[1a, 3b]

Scheme 1.

Scheme 1

A) Two different approaches used to install isonitrile. B) Fe/2OG enzyme catalyzed hydroxylation.

The majority of Fe/2OG enzymes catalyze two-electron oxidative modifications that include hydroxylation, desaturation, epoxidation, halogenation and endoperoxide installation.[4] Addition of O2 to the 2OG bound Fe(II) generates an Fe(IV)-oxo species which is used to activate the targeted C-H bond or acts as an oxygen atom donor to add onto the olefin moiety.[5] For those involving C-H activation, subsequent to hydrogen atom (H•) abstraction, an iron bound ligand transfers to the substrate radical to form the product and regenerates the Fe(II) (Scheme 1B).[4d, 6]

Differently, Fe/2OG enzyme catalyzed isonitrile formation is a four-electron oxidation and formally involves two C-H bond cleavage steps and a decarboxylation. Initial biochemical and structural characterizations of ScoE suggested that it is responsible for isonitrile formation.[3] The structure of zinc-bound ScoE indicates that it belongs to the cupin superfamily and has the 2-His-1-carboxylate triad as the iron-binding ligands.[3a] However, in this structure, the potential substrate binding site and 2OG binding site are occupied by choline and acetate, respectively. Based on this structure, the reaction mechanism has been postulated to involve a hydroxylated imine species (5) that is likely generated via hydroxylation of the imine intermediate (4). Subsequent dehydration/decarboxylation of 5 produces 2 (Scheme 2, pathway i). To date, this is the only experimentally characterized Fe/2OG isonitrile forming enzyme. To demonstrate a conserved approach may be utilized in introducing isonitrile functionality among isonitrile-containing peptides production, we use crystallographic, biochemical and biophysical methods to study three enzymes, Sav607, ScoE and SfaA, originated from Streptomyces avermitilis, S. coeruleorubidus and S. thioluteus, that are known, or are predicted, to catalyze isonitrile formation.[1a, 3b, 7]

Scheme 2.

Scheme 2

Possible pathways for isonitrile formation. Starting from C5-hydroxylation, two pathways involving either second hydroxylation (pathway i) or decarboxylation-assisted desaturation (pathway ii) are proposed.

To overcome the reported issues of co-purification of zinc and choline with the protein, and the instability of the product that hamper direct mechanistic studies and structural analysis,[3a] we expressed and purified Sav607, ScoE and SfaA as metal-free proteins by chelating the co-purified metal using EDTA and then introduced Fe(II) in all experiments. A synthetic approach was developed to afford substrate (1), its isotope-labeled analogs ([5-2H2-1] and [5-13C-1]), 2, and mechanistic probes (cis-4 and 6) (detailed in Supporting Information (SI)).

We first carried out structural analysis. All three proteins were subjected to crystallization conditions, the ScoE and SfaA samples yielded diffraction quality crystals. Co-crystals of 1 and presumptive intermediate (3) bound ScoE were obtained by the sitting drop vapor diffusion technique (detailed in the SI). The structure of 1 and iron bound ScoE (ScoE•Fe•1) was then solved at a resolution of 2.18 Å. The overall structure contains 15 strands of β-sheet and 8 α-helices, eight of which forming a jellyroll motif (β3, β13, β5, β15, β4 and β12, β6, β14) (Figure 1AB, S20 and Table S4). Dali search suggested the structure of ScoE resembles those of other Fe/2OG-enzymes such as CarC (PDB ID: 4oj8) and a putative dioxygenases (PDB ID: 4y0e), with Z-score of 20.0 and 26.7, respectively. In the structure of ScoE, the octahedron geometry of iron is bound by a 2-His-1-Asp facial triad (H132, D134, and H295). The fourth coordination site is occupied by a tartrate (TAR) molecule that is acquired during crystallization. The remaining two coordination positions are occupied by water molecules (W1 and W2). Significant electron density corresponding to 1 is visualized in the active site which has hydrogen-bonding interactions with Y101, K193, G128, Y96, Y135 and R310. Importantly, this structure implies the plausible reaction site where the C5 of 1 is 4.9 Å away from the iron with one of its hydrogens pointing toward to the iron. Compared to other Fe/2OG enzyme structures including TauD (PDB ID: 1os7), CarC (PDB ID: 4oj8), and PvcB (PDB ID: 3eat), a tartrate molecule is most likely positioned at the 2OG binding site. A putative quaternary complex structure of ScoE•Fe•2OG•1 is modeled by docking the 2OG molecule into the substrate structure (Figure S20). In addition, a presumptive intermediate (3) bound ScoE structure with resolution of 2.17 Å was obtained (Figure 1BC, S21, S22, S23 and Table S4). The electron density map of the structure clearly shows that this compound resembles the possible C5 hydroxylated product (3). Besides, the apo form of SfaA is highly similar to the structure of ScoE with root mean square deviation (rmsd) of ~0.37 Å (Figure S24 and Table S4).

Figure 1.

Figure 1.

Crystal structures of ScoE. A) The overall structure of ScoE is shown in cartoon model, with the jellyroll motif colored in cyan. 2Fo-Fc (light gray mesh, contoured at 1.0 σ) electron density map for 1. Dashed lines illustrate hydrogen-bonding interactions involving 1 or bonds between the iron and its ligands. B) Active site of ScoE in the presence of 1 or 3. Putative 2OG binding sites appear to be occupied by exogenous ligands (TAR and FMT). The 2-His-1-Asp triad is shown in wheat stick format. Molecules 1 and 3 are colored in cyan, the electron density maps for 1 and 3 are shown in dark-gray mesh and contoured at 1.0 σ. Iron and waters are shown in orange and red sphere. Putative 2OG binding sites appear to be occupied by exogenous ligands (TAR or FMT) colored in forest. C) Superposition of ScoE•Fe•1 and ScoE•Fe•3.

To establish the reaction pathway, the stoichiometry between 2OG and 1 was established. During Fe/2OG enzyme reaction, the Fe(II) is converted to the Fe(IV)-oxo species by reacting with O2 and 2OG where 2OG is converted to succinate and CO2 (Scheme 1B). Thus, the stoichiometry of 2OG and 1 can be established by quantifying succinate, and the isonitrile (2). Reactions with different amount of 2OG were carried out and analyzed by LC-MS (see the Supporting Information). As depicted in Figure S16, the peak with the same retention time and mass/charge (m/z) as the synthetic 2 accumulated when 2OG and O2 were introduced. By quantifying succinate and 2, the stoichiometry between succinate and 2 is determined as 2.3, 3.2 and 4.5 for SfaA, Sav607 and ScoE, respectively (see Figure S17). Compared to SfaA, the higher uncoupling ratio observed in Sav607 and ScoE possibly arise from unproductive pathways. Similar uncoupling reactions have been observed in other Fe/2OG enzymes.[8] These results suggest that for one equivalent of 2 produced, two equivalents of 2OG are required. Thus, isonitrile group installation likely involves two sequential reactions.

The presence of 3 was established by the analysis of the 13C-NMR spectrum of a sample prepared by reacting SfaA with 5-13C-1, O2 and 2OG (with the molar ratio of 5-13C-1 to 2OG of 1:1.5). The spectrum recorded under C-H decoupling mode exhibits a new peak at ~91 ppm that is not present in the absence of 2OG. The spectrum collected under C-H coupling mode reveals a doublet with a coupling constant of ~163 Hz (Figure 2 and S15). The chemical shift and the coupling pattern indicate that this carbon is connected to one proton, one carbon and two heteroatoms. This result is consistent with the ScoE•Fe•1 structure where the C5-H of 1 points toward the iron and observation of the ScoE•Fe•3 structure. When the ratio of 5-13C-1 to 2OG changed from 1:1.5 to 1:2.5, we observed a decrease of this species (3) and the appearance of the new peak centered at ~150 ppm. The NMR spectrum obtained under C-H coupling mode indicates that no proton is connected to this newly formed carbon. This newly formed peak has the same chemical shift as of the synthetic 2 (see Figures S11 and S15). These results suggest that the isonitrile formation is at the expense of 2OG and 3 serves as the possible intermediate during isonitrile formation.

Figure 2.

Figure 2.

13C NMR spectra of SfaA catalyzed 2 formation under C-H decoupling and C-H coupling conditions. The top, middle and bottom traces represent the 13C-NMR recorded with 5-13C-1 to 2OG ratio at 1:0, 1:1.5 and 1:2.5, respectively.

The requirement for the Fe(IV)-oxo, a.k.a. ferryl, species to cleave C5-H bond is verified by the Mössbauer analysis. Samples were prepared by mixing the SfaA•Fe(II)•2OG•1 or 5-2H2-1 complex (the quaternary complex) with oxygenated buffer and freeze quenching at various time points. The Mössbauer spectra of SfaA•Fe(II)•2OG•1 or 5-2H2-1 complex exhibit a quadrupole doublet with an isomer shift (δ) of 1.23 mm/s and quadrupole splitting (ΔEQ) of 2.74 mm/s, which represents high-spin ferrous species (Figure 3, S19 and Table S1S3). When 5-2H2-1 was used, the sample quenched at 0.03 s showed ~30% decrease of the SfaA•Fe(II)•2OG•5-2H2-1 complex with the simultaneous accumulation of a species with parameters of δ = 0.31 mm/s and ΔEQ = 0.59 mm/s, representing about 20% of the total iron. This new species is similar to the ferryl intermediate observed in other Fe/2OG enzymes.[5b, 9] In addition, a minor ferrous species with parameters of δ = 1.25 mm/s and ΔEQ = 1.90 mm/s (~13% of the iron in the sample) was also observed. This ferrous species was more readily accumulated in the sample quenched at 0.03 s when 1 was used, which represented ~ 25% of the total iron. We tentatively assign this ferrous species as a potential product complex. Importantly, compared to the reaction using 5-2H2-1, the sample quenched at 0.03 s using 1 did not show a significant accumulation of the ferryl intermediate (< 5%). Thus, accumulation of the ferryl species using 5-2H2-1 is likely due to the kinetic isotope effect from the replacement of the targeted C5-H bond with the C5-D bond. Overall, Mössbauer analysis suggests that the initial C-H activation by the ferryl intermediate occurs at the C5 position of 1.

Figure 3.

Figure 3.

The Mössbauer spectra of SfaA•Fe(II)•2OG•5-2H2-1 and SfaA•Fe(II)•2OG•1 are shown in A and E; The spectra of the samples quenched at 0.03 s are shown in B and F; The difference spectra between A and B (B-A), E and F (F-E), and the spectral simulations (grey lines) are shown in C and G, which indicate the decrease of the quaternary complex (upward blue simulations), the accumulation of the ferryl intermediate (the red simulations) and the additional ferrous species (the green simulations in D and H). See Table S1S3 for details simulation parameters.

In the structure of ScoE•Fe•3, the C5 of 3 moves ~0.4 Å closer to the iron center (4.9 → 4.5 Å from ScoE•Fe•3 to ScoE•Fe•1). However, the orientation of 3 is probably not at optimal position for H• abstraction where the C5-H is not pointing toward the iron. Meanwhile, the N atom located ~5.9 Å away from the iron center may also not be properly positioned to interact with the iron (Figure 1C, Figure S22). To reveal possible pathway involved in the second reaction, the proposed intermediates 4 and 6 were synthesized. As shown in Scheme 2, pathway i, following with hydroxylation at C5 of 4, 5, which likely tautomerizes to 6 rapidly, may proceed through dehydration/decarboxylation to produce 2. Alternatively, second hydroxylation of 3 will produce 6 through the proposed intermediate 7. After incubating enzyme, Fe, 2OG, O2 and cis-4, the reactions were analyzed by LC-MS. Under the current conditions, no production of 2 can be detected. When 6 was tested with enzyme under anoxic conditions or in the presence of 2OG and O2, production of 2 was not observed (Figure S18). Although it is possible that cis-4 or 6 cannot enter the active site, or the trans-4 serves as the actual intermediate, these results imply the pathway involving 4 or 6 is less likely and suggest that the alternative pathway may be utilized (pathway ii) where isonitrile formation possibly involves a reactive iron species assisted decarboxylation. Namely, during the second reaction, the presumptive ferryl species is used to trigger decarboxylation by activating the N and the reaction is then followed by dehydration (382). Alternatively, subsequent to dehydration of 3, an analogous decarboxylation will result in protonated isonitrile (9). Although it is less common, desaturation via oxidative decarboxylation has been reported in several Fe/2OG enzymes catalyzed olefination.[10] In addition, N-hydroxylation was reported in a non-heme iron enzyme catalyzed reaction in streptozotocin biosynthesis.[11]

In short, in studying three Fe/2OG enzyme catalyzed isonitrile installation, the experimental analyses establish that isonitrile formation goes through two consecutive, but distinctive, reactions. In the first reaction, an Fe(IV)-oxo species is utilized to generate 3. Conversion of 3 to 2 likely proceeds by decarboxylation-assisted desaturation. Although the detailed mechanism remains to be evaluated, these observations enrich our view in diverse strategies that Fe/2OG enzymes used to catalyze novel reactions. Considering the conserved biosynthetic approach used to install the isonitrile-containing peptides found in several pathogenic bacteria, these observations may shed light for development of new anti-virulence therapeutics target for bacterial infection.

Supplementary Material

supporting information

Acknowledgements

This work was supported by North Carolina State University, Carnegie Mellon University, grants from the National Key Research and Development Program of China (2018YFA0901900 to J.Z.), Shanghai Municipal Science and Technology Commission (19XD1404800 to J.Z.), and the National Institutes of Health (GM127588 to W.-c. C., and Y. G.). We thank the staffs in beamline BL17U1 and BL19U1 of Shanghai Synchrotron Radiation Facility for help in data collection. We also thank Prof. Jianhua Gan for his help in structure refinement.

Footnotes

Supporting information for this article is given via a link at the end of the document.

References

  • [1].a) Wang LJ, Zhu MY, Zhang QB, Zhang X, Yang PL, Liu ZH, Deng Y, Zhu YG, Huang XS, Han L, Li SQ, He J, ACS Chem. Biol 2017, 12, 3067–3075; [DOI] [PubMed] [Google Scholar]; b) Crawford JM, Portmann C, Zhang X, Roeffaers MBJ, Clardy J, Proc. Natl. Acad. Sci. U.S.A 2012, 109, 10821–10826; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Mo SY, Krunic A, Chlipala G, Orjala J, J. Nat. Prod 2009, 72, 894–899; [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Clarke-Pearson MF, Brady SF, J. Bacteriol 2008, 190, 6927–6930; [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Brady SF, Clardy J, Angew. Chem. Int. Ed. Engl 2005, 44, 7063–7065; [DOI] [PubMed] [Google Scholar]; f) Garson MJ, Simpson JS, Nat. Prod. Rep 2004, 21, 164–179; [DOI] [PubMed] [Google Scholar]; g) Stratmann K, Moore RE, Bonjouklian R, Deeter JB, Patterson GML, Shaffer S, Smith CD, Smitka TA, J. Am. Chem. Soc 1994, 116, 9935–9942; [Google Scholar]; h) Parker WL, Rathnum ML, Johnson JH, Wells JS, Principe PA, Sykes RB, J. Antibiot 1988, 41, 454–460; [DOI] [PubMed] [Google Scholar]; i) Chang CWJ, Patra A, Roll DM, Scheuer PJ, Matsumoto GK, Clardy J, J. Am. Chem. Soc 1984, 106, 4644–4646. [Google Scholar]
  • [2].a) Chang W.-c., Sanyal D, Huang JL, Ittiamornkui K, Zhu Q, Liu X, Org. Lett 2017, 19, 1208–1211; [DOI] [PubMed] [Google Scholar]; b) Brady SF, Clardy J, Angew. Chem. Int. Ed. Engl 2005, 44, 7045–7048. [DOI] [PubMed] [Google Scholar]
  • [3].a) Harris NC, Born DA, Cai WL, Huang YB, Martin J, Khalaf R, Drennan CL, Zhang WJ, Angew. Chem. Int. Ed. Engl 2018, 57, 9707–9710; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Harris NC, Sato M, Herman NA, Twigg F, Cai WL, Liu J, Zhu XJ, Downey J, Khalaf R, Martin J, Koshino H, Zhang WJ, Proc. Natl. Acad. Sci. U.S.A 2017, 114, 7025–7030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].a) Islam MS, Leissing TM, Chowdhury R, Hopkinson RJ, Schofield CJ, Annu. Rev. Biochem 2018, 87, 585–620; [DOI] [PubMed] [Google Scholar]; b) Gao SS, Naowarojna N, Cheng R, Liu X, Liu, Nat. Prod. Rep 2018, 35, 792–837; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Martinez S, Hausinger RP, J. Biol. Chem 2015, 290, 20702–20711; [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Bollinger JM Jr.;, Chang W.-c., Matthews ML, Martinie RJ, Boal AK, Krebs C, in 2-Oxoglutarate-Dependent Oxygenases (Eds.: Hausinger RP, Schofield CJ), Royal Society of Chemistry; 2015, pp. 95–122. [Google Scholar]
  • [5].a) Price JC, Barr EW, Tirupati B, Bollinger JM Jr., Krebs C, Biochemistry 2003, 42, 7497–7508; [DOI] [PubMed] [Google Scholar]; b) Price JC, Barr EW, Glass TE, Krebs C, Bollinger JM Jr., J. Am. Chem. Soc 2003, 125, 13008–13009. [DOI] [PubMed] [Google Scholar]
  • [6].Hausinger RP, in 2-Oxoglutarate-Dependent Oxygenases (Eds.: Hausinger RP, Schofield CJ), Royal Society of Chemistry, 2015, pp. 1–58. [Google Scholar]
  • [7].Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H, Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Proc. Natl. Acad. Sci. U.S.A 2001, 98, 12215–12220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].a) Chang W.-c., Guo Y, Wang C, Butch SE, Rosenzweig AC, Boal AK, Krebs C, Bollinger JM Jr., Science 2014, 343, 1140–1144; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Dunham NP, Chang W.-c., Mitchell AJ, Martinie RJ, Zhang B, Bergman JA, Rajakovich LJ, Wang B, Silakov A, Krebs C, Boal AK, Bollinger JM Jr., J. Am. Chem. Soc 2018, 140, 7116–7126; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Mitchell AJ, Dunham NP, Bergman JA, Wang B, Zhu Q, Chang W.-c., Liu X, Boal AK, Biochemistry 2017, 56, 441–444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Chang W.-c., Li J, Lee JL, Cronican AA, Guo Y, J. Am. Chem. Soc 2016, 138, 10390–10393. [DOI] [PubMed] [Google Scholar]
  • [10].a) Yu CP, Tang Y, Cha L, Milikisiyants S, Smirnova TI, Smirnov AI, Guo Y, Chang W.-c., J. Am. Chem. Soc 2018, 140, 15190–15193; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Zhu J, Lippa GM, Gulick AM, Tipton PA, Biochemistry 2015, 54, 2659–2669; [DOI] [PubMed] [Google Scholar]; c) Huang JL, Tang Y, Yu CP, Sanyal D, Jia X, Liu X, Guo Y, Chang W.-c., Biochemistry 2018, 57, 1838–1841. [DOI] [PubMed] [Google Scholar]
  • [11].a) Ng TL, Rohac R, Mitchell AJ, Boal AK, Balskus EP, Nature 2019, 566, 94–99; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) He HY, Henderson AC, Du YL, Ryan KS, J. Am. Chem. Soc 2019, 141, 4026–4033. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supporting information

RESOURCES